Renal Function and All-Cause Mortality Risk Among Cancer Patients

被引:42
作者
Yang, Yan [1 ]
Li, Hui-yan [1 ]
Zhou, Qian [1 ]
Peng, Zhen-wei [2 ]
An, Xin [3 ]
Li, Wei [1 ]
Xiong, Li-ping [1 ]
Yu, Xue-qing [1 ]
Jiang, Wen-qi [3 ]
Mao, Hai-ping [1 ]
机构
[1] Sun Yat Sen Univ, Key Lab Nephrol, Minist Hlth China,Dept Nephrol, Guangdong Prov Key Lab Nephrol,Affiliated Hosp 1, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Dept Oncol, 651 Dongfeng Rd, Guangzhou 510080, Guangdong, Peoples R China
关键词
CHRONIC KIDNEY-DISEASE; COLORECTAL-CANCER; SURGICAL RESECTION; LUNG-CANCER; COMORBIDITY; INSUFFICIENCY; THERAPY; IMPACT; AGE; IMPAIRMENT;
D O I
10.1097/MD.0000000000003728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction predicts all-cause mortality in general population. However, the prevalence of renal insufficiency and its relationship with mortality in cancer patients are unclear. We retrospectively studied 9465 patients with newly diagnosed cancer from January 2010 to December 2010. Renal insufficiency was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2) using the Chronic Kidney Disease Epidemiology Collaboration equation. The hazard ratio (HR) of all-cause mortality associated with baseline eGFR was assessed by Cox regression. Three thousand sixty-nine patients (32.4%) exhibited eGFR < 90 mL/min/1.73 m(2) and 3% had abnormal serum creatinine levels at the time of diagnosis. Over a median follow-up of 40.5 months, 2705 patients (28.6%) died. Compared with the reference group (eGFR >= 60 mL/min/1.73 m 2), an elevated all-cause mortality was observed among patients with eGFR< 60 mL/min/1.73 m(2) stratified by cancer stage in the entire cohort, the corresponding hazard ratios were 1.87 (95% CI, 1.41-2.47) and 1.28 (95% CI, 1.01-1.62) for stage I to III and stage IV, respectively. However, this relationship was not observed after multivariate adjustment. Subgroup analysis found that eGFR< 60 mL/min/1.73m 2 independently predicted death among patients with hematologic (adjusted HR 2.93, 95% CI [1.36-6.31]) and gynecological cancer (adjusted HR 2.82, 95% CI [1.19-6.70]), but not in those with other cancer. Five hundred fifty-seven patients (6%) had proteinuria. When controlled for potential confounding factors, proteinuria was a risk factor for all-cause mortality among patients in the entire cohort, regardless of cancer stage and eGFR values. When patients were categorized by specific cancer type, the risk of all-cause death was only significant in patients with digestive system cancer (adjusted HR, 1.85 [1.48-2.32]). The prevalence of renal dysfunction was common in patients with newly diagnosed cancer. Patients with eGFR < 60 mL/min/1.73 m(2) or proteinuria were associated with increased risk for all-cause mortality, this relation depended on cancer site.
引用
收藏
页数:8
相关论文
共 35 条
[21]   Lung Cancer and Renal Insufficiency: Prevalence and Anticancer Drug Issues [J].
Launay-Vacher, Vincent ;
Etessami, Reza ;
Janus, Nicolas ;
Spano, Jean-Philippe ;
Ray-Coquard, Isabelle ;
Oudard, Stephane ;
Gligorov, Joseph ;
Pourrat, Xavier ;
Beuzeboc, Philippe ;
Deray, Gilbert ;
Morere, Jean-Francois .
LUNG, 2009, 187 (01) :69-74
[22]   Renal impairment and late toxicity in germ-cell cancer survivors [J].
Lauritsen, J. ;
Mortensen, M. S. ;
Kier, M. G. G. ;
Christensen, I. J. ;
Agerbaek, M. ;
Gupta, R. ;
Daugaard, G. .
ANNALS OF ONCOLOGY, 2015, 26 (01) :173-178
[23]   A New Equation to Estimate Glomerular Filtration Rate [J].
Levey, Andrew S. ;
Stevens, Lesley A. ;
Schmid, Christopher H. ;
Zhang, Yaping ;
Castro, Alejandro F., III ;
Feldman, Harold I. ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Greene, Tom ;
Coresh, Josef .
ANNALS OF INTERNAL MEDICINE, 2009, 150 (09) :604-612
[24]   Short-Term and Long-Term Outcomes After Gastrectomy for Gastric Cancer in Patients With Chronic Kidney Disease [J].
Matsumoto, Sohei ;
Takayama, Tomoyoshi ;
Wakatsuki, Kohei ;
Tanaka, Tetsuya ;
Migita, Kazuhiro ;
Nakajima, Yoshiyuki .
WORLD JOURNAL OF SURGERY, 2014, 38 (06) :1453-1460
[25]   Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate [J].
Matsushita, Kunihiro ;
Mahmoodi, Bakhtawar K. ;
Woodward, Mark ;
Emberson, Jonathan R. ;
Jafar, Tazeen H. ;
Jee, Sun Ha ;
Polkinghorne, Kevan R. ;
Shankar, Anoop ;
Smith, David H. ;
Tonelli, Marcello ;
Warnock, David G. ;
Wen, Chi-Pang ;
Coresh, Josef ;
Gansevoort, Ron T. ;
Hemmelgarn, Brenda R. ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (18) :1941-1951
[26]   Chronic Kidney Disease in Cancer Patients: An Independent Predictor of Cancer-Specific Mortality [J].
Na, Sun Young ;
Sung, Ji Yoon ;
Chang, Jae Hyun ;
Kim, Sejoong ;
Lee, Hyun Hee ;
Park, Yeon Ho ;
Chung, Wookyung ;
Oh, Kook-Hwan ;
Jung, Ji Yong .
AMERICAN JOURNAL OF NEPHROLOGY, 2011, 33 (02) :121-130
[27]   Impact of Chronic Kidney Disease on Outcomes of Surgical Resection for Primary Colorectal Cancer: A Retrospective Cohort Review [J].
Nozawa, Hiroaki ;
Kitayama, Joji ;
Sunami, Eiji ;
Watanabe, Toshiaki .
DISEASES OF THE COLON & RECTUM, 2012, 55 (09) :948-956
[28]   Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation [J].
Oshima, Kumi ;
Kanda, Yoshinobu ;
Nanya, Yasuhito ;
Tanaka, Masatsugu ;
Nakaseko, Chiaki ;
Yano, Shingo ;
Fujisawa, Shin ;
Fujita, Hiroyuki ;
Yokota, Akira ;
Takahashi, Satoshi ;
Kanamori, Heiwa ;
Okamoto, Shinichiro .
ANNALS OF HEMATOLOGY, 2013, 92 (02) :255-260
[29]   CKD-EPI and Cockcroft-Gault Equations Identify Similar Candidates for Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer [J].
Pal, Sumanta K. ;
Ruel, Nora ;
Villegas, Sergio ;
Chang, Mark ;
DeWalt, Kara ;
Wilson, Timothy G. ;
Vogelzang, Nicholas J. ;
Yuh, Bertram E. .
PLOS ONE, 2014, 9 (04)
[30]   Impact of Age, Sex, and Comorbidity on Cancer Therapy and Disease Progression [J].
Pal, Sumanta Kumar ;
Hurria, Arti .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (26) :4086-4093